Advertisement

Fluvoxamine is Poorly Tolerated by Alcoholics

  • H. Kranzler
  • F. Del Boca
  • P. Korner
  • J. Brown
Conference paper

Abstract

Fluvoxamine maleate is a monocyclic antidepressant that potently and selectively inhibits presynaptic serotonin reuptake (Claasen et al. 1977). In addition to their antidepressant effects, selective serotonin-uptake inhibitors (SUIs), have been shown to reduce ethanol consumption in both rodents and non-depressed, heavy drinking humans (Gorelick 1986, Naranjo et al. 1984, 1986, 1987, 1989, 1990). To test the utility of fluvoxamine as an adjunct to relapse prevention treatment, we conducted an open trial (OT) in 16 subjects (13 males) and then initiated a placebo-controlled, double-blind trial (CT) in 19 subjects (18 males). All subjects met DSM III-R criteria for alcohol dependence (APA 1987). Subjects were excluded if they met criteria for current drug (other than nicotine) dependence or if they had a medical or psychiatric disorder that contraindicated treatment with fluvoxamine.

Keywords

Alcohol Dependence Open Trial Complete Group Intolerable Side Effect Fluvoxamine Treatment 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Copyright information

© Springer-Verlag New York, Inc. 1992

Authors and Affiliations

  • H. Kranzler
  • F. Del Boca
  • P. Korner
  • J. Brown

There are no affiliations available

Personalised recommendations